https://www.nature.com/articles/d41586-023-00283-y Skip to main content Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript. Advertisement Advertisement Nature * View all journals * Search * Log in * Explore content * About the journal * Publish with us * Subscribe * Sign up for alerts * RSS feed 1. nature 2. news 3. article * NEWS * 14 February 2023 WHO abandons plans for crucial second phase of COVID-origins investigation Sensitive studies in China were intended to pinpoint the source of the pandemic virus. * Smriti Mallapaty 1. Smriti Mallapaty View author publications You can also search for this author in PubMed Google Scholar * Twitter * Facebook * Email You have full access to this article via your institution. Download PDF Delegates from the World Health Organisation speak with scientists in a medical facility in Wuhan, February 2020 An expert team convened by the World Health Organization met Chinese researchers in Wuhan in February 2020 to review when and how SARS-CoV-2 might have emerged.Credit: Top Photo Corporation/ Shutterstock The World Health Organization (WHO) has quietly shelved the second phase of its much-anticipated scientific investigation into the origins of the COVID-19 pandemic, citing ongoing challenges over attempts to conduct crucial studies in China, Nature has learned. Researchers say they are disappointed that the investigation isn't going ahead, because understanding how the coronavirus SARS-CoV-2 first infected people is important for preventing future outbreaks. But without access to China, there is little that the WHO can do to advance the studies, says Angela Rasmussen, a virologist at the University of Saskatchewan in Saskatoon, Canada. "Their hands are really tied." In January 2021, an international team of experts convened by the WHO travelled to Wuhan, China, where the virus that causes COVID-19 was first detected. Together with Chinese researchers, the team reviewed evidence on when and how the virus might have emerged, as part of phase one. The team released a report in March that year outlining four possible scenarios, the most likely being that SARS-CoV-2 spread from bats to people, possibly through an intermediate species. Phase one was designed to lay the groundwork for a second phase of in-depth studies to pin down exactly what happened in China and elsewhere. But two years since that high-profile trip, the WHO has abandoned its phase-two plans. "There is no phase two," Maria Van Kerkhove, an epidemiologist at the WHO in Geneva, Switzerland, told Nature. The WHO planned for work to be done in phases, she said, but "that plan has changed". "The politics across the world of this really hampered progress on understanding the origins," she said. Researchers are undertaking some work to pin down a timeline of the virus's initial spread. This includes efforts to trap bats in regions bordering China in search of viruses closely related to SARS-CoV-2; experimental studies to help narrow down which animals are susceptible to the virus and could be hosts; and testing of archived wastewater and blood samples collected around the world in late 2019 and early 2020. But researchers say that too much time has passed to gather some of the data needed to pinpoint where the virus originated. Tense times Many researchers aren't surprised the WHO's plans have been thwarted. In early 2020, members of then US president Donald Trump's administration made unsubstantiated claims that the virus had originated in a Chinese laboratory, and US intelligence officials later said they had begun investigations. The city of Wuhan is home to the Wuhan Institute of Virology, a high-security lab that works on coronaviruses. Chinese officials questioned whether the virus originated inside the country's borders. In the midst of simmering hostility between the two superpowers, WHO member states requested in May 2020 that the agency put together a science-led effort to identify how the pandemic started. Although China agreed to the mission, tensions were high by the time the WHO group left for Wuhan, and engagement with China quickly unravelled after the group returned. In its March 2021 report, the team concluded that it was "extremely unlikely" that the virus accidentally escaped from a laboratory. But the inclusion of the lab-incident scenario in the final report was a key point of contention for Chinese researchers and officials, says Dominic Dwyer, a virologist at New South Wales Health Pathology in Sydney, who was a member of the WHO team. That July, the WHO sent a circular to member states outlining how it planned to advance origins studies. Proposed steps included assessing wild-animal markets in and around Wuhan and the farms that supplied those markets, as well as audits of labs in the area where the first cases were identified. But Chinese officials rejected the WHO's plans, taking particular issue with the proposal to investigate lab breaches. Zhao Lijian, the spokesperson for China's foreign ministry, said the WHO proposal was not agreed by all member states, and that the second phase should not focus on pathways the mission report had already deemed extremely unlikely. In August 2021, members of the original mission team published a Comment piece in Nature urging quick action on the proposed studies to trace the virus's origins. "We wrote that piece because we were worried phase two might not happen," says Marion Koopmans, a virologist at Erasmus University Medical Center in Rotterdam, the Netherlands, and a member of the mission to Wuhan. "I'm sorry to say that that's indeed what panned out." Stalled work Gerald Keusch, associate director of the National Emerging Infectious Diseases Laboratory Institute at Boston University in Massachusetts, says the origins investigation was "poorly handled by the global community. It was poorly handled by China. It was poorly handled by the WHO." The WHO should have been relentless in creating a positive working relationship with the Chinese authorities, says Keusch; if it was being stonewalled, it should have been honest about that. Van Kerkhove says that the WHO's director-general, Tedros Adhanom Ghebreyesus, has continued to directly engage with Chinese government officials to encourage China to be more open and to share data. And WHO staff have reached out to the China Center for Disease Control and Prevention in Beijing to try to establish collaborations. "We really, really want to be able to work with our colleagues there," says Van Kerkhove. "It's really a deep frustration." The Chinese ministry of foreign affairs did not respond to Nature's e-mailed requests for comment on why the phase-two studies have stalled. In November 2021, the WHO formed the Scientific Advisory Group for the Origins of Novel Pathogens (SAGO) -- a permanent team of experts who have since written a proposal for how to conduct origins studies for future outbreaks. SAGO has also evaluated evidence on the origins of SARS-CoV-2. Blood-donors study Outside the formal WHO-led process, some studies proposed for phase two have gone ahead. In May last year, researchers in Beijing and Wuhan published the results^1 of an analysis of donor blood supplied to the Wuhan Blood Center before December 2019. The researchers were looking for SARS-CoV-2 antibodies that could signify some of the earliest infections in the pandemic. The team screened more than 88,000 plasma samples collected between 1 September and 31 December 2019, but did not find any SARS-CoV-2-blocking antibodies in the samples. Michael Worobey, an evolutionary virologist at the University of Arizona in Tucson, says the work is an important contribution from Chinese scientists, supporting earlier genomic analyses^2 showing that the virus probably had not emerged as early as September and was not widespread in Wuhan in late 2019. Another study^3 by researchers from China, which has not been peer reviewed, reported finding traces of SARS-CoV-2 in January and February 2020 at the Huanan seafood market in Wuhan, which was visited by many of the earliest known people with COVID-19^4. Samples were taken from sewage, drains, the surfaces of doors and market stalls, and from the ground, among other places. The researchers concluded that the virus was probably shed by humans, but Rasmussen and others are keen to take a closer look at the raw data, which included swabs from a defeathering machine, to see whether they can identify animal species. "I still hope that progress will be made," says Thea Fischer, a public-health virologist at the University of Copenhagen, who was a member of the mission to Wuhan and is part of SAGO. doi: https://doi.org/10.1038/d41586-023-00283-y References 1. Chang, L. et al. Protein Cell 14, 28-36 (2023). Article PubMed Google Scholar 2. Pekar, J. et al. Science 372, 412-417 (2021). Article PubMed Google Scholar 3. Gao, G. et al. Preprint at Research Square https://doi.org/ 10.21203/rs.3.rs-1370392/v1 (2022). 4. Worobey, M. et al. Science 377, 951-959 (2022). Article PubMed Google Scholar Download references Related Articles * [d41586-023] Wuhan market was epicentre of pandemic's start, studies suggest * [d41586-023] After the WHO report: what's next in the search for COVID's origins * [d41586-023] Coronapod: COVID's origins and the 'lab leak' theory * [d41586-023] WHO report into COVID pandemic origins zeroes in on animal markets, not labs * [d41586-023] Meet the scientists investigating the origins of the COVID pandemic Subjects * SARS-CoV-2 * Politics * Virology * Public health Latest on: SARS-CoV-2 An abundance of antibiotics, and more -- this week's best science graphics An abundance of antibiotics, and more -- this week's best science graphics News 07 FEB 23 Global pandemic treaty: what we must learn from climate-change errors Global pandemic treaty: what we must learn from climate-change errors Editorial 07 FEB 23 COVID drug drives viral mutations -- and now some want to halt its use COVID drug drives viral mutations -- and now some want to halt its use News 07 FEB 23 Politics UK, please drop the rhetoric and fight for collaboration with Europe UK, please drop the rhetoric and fight for collaboration with Europe Editorial 14 FEB 23 UK government announces new science department and minister UK government announces new science department and minister News 07 FEB 23 India pledges $4 billion for green energy to cut carbon emissions India pledges $4 billion for green energy to cut carbon emissions News 03 FEB 23 Virology The structural basis for HIV-1 Vif antagonism of human APOBEC3G Article 08 FEB 23 Babies collect their own viruses rather than relying on Mum's Babies collect their own viruses rather than relying on Mum's Research Highlight 08 FEB 23 An abundance of antibiotics, and more -- this week's best science graphics An abundance of antibiotics, and more -- this week's best science graphics News 07 FEB 23 Nature Careers Jobs * Faculty Positions in Natural and Applied Sciences Duke Kunshan University Kunshan, Jiangsu, China * Research Faculty University of Maryland, Baltimore (UMB) Baltimore, MD, United States * Faculty of Medicine and Health Sciences - Department of Surgery, Division of Urology McGill University Montreal, Quebec, Canada * Cooperative Agreement/Land Management Supervisor - Schofield Barracks, Hawaii Colorado State University Fort Collins, CO, United States You have full access to this article via your institution. Download PDF Related Articles * [d41586-023] Wuhan market was epicentre of pandemic's start, studies suggest * [d41586-023] After the WHO report: what's next in the search for COVID's origins * [d41586-023] Coronapod: COVID's origins and the 'lab leak' theory * [d41586-023] WHO report into COVID pandemic origins zeroes in on animal markets, not labs * [d41586-023] Meet the scientists investigating the origins of the COVID pandemic Subjects * SARS-CoV-2 * Politics * Virology * Public health Advertisement Sign up to Nature Briefing An essential round-up of science news, opinion and analysis, delivered to your inbox every weekday. Email address [ ] [ ] Yes! Sign me up to receive the daily Nature Briefing email. I agree my information will be processed in accordance with the Nature and Springer Nature Limited Privacy Policy. Sign up * Close Nature Briefing Sign up for the Nature Briefing newsletter -- what matters in science, free to your inbox daily. Email address [ ] Sign up [ ] I agree my information will be processed in accordance with the Nature and Springer Nature Limited Privacy Policy. Close Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing Explore content * Research articles * News * Opinion * Research Analysis * Careers * Books & Culture * Podcasts * Videos * Current issue * Browse issues * Collections * Subjects * Follow us on Facebook * Follow us on Twitter * Subscribe * Sign up for alerts * RSS feed About the journal * Journal Staff * About the Editors * Journal Information * Our publishing models * Editorial Values Statement * Journal Metrics * Awards * Contact * Editorial policies * History of Nature * Send a news tip Publish with us * For Authors * For Referees * Language editing services * Submit manuscript Search Search articles by subject, keyword or author [ ] Show results from [All journals] Search Advanced search Quick links * Explore articles by subject * Find a job * Guide to authors * Editorial policies Nature (Nature) ISSN 1476-4687 (online) ISSN 0028-0836 (print) nature.com sitemap About Nature Portfolio * About us * Press releases * Press office * Contact us Discover content * Journals A-Z * Articles by subject * Nano * Protocol Exchange * Nature Index Publishing policies * Nature portfolio policies * Open access Author & Researcher services * Reprints & permissions * Research data * Language editing * Scientific editing * Nature Masterclasses * Nature Research Academies * Research Solutions Libraries & institutions * Librarian service & tools * Librarian portal * Open research * Recommend to library Advertising & partnerships * Advertising * Partnerships & Services * Media kits * Branded content Career development * Nature Careers * Nature Conferences * Nature events Regional websites * Nature Africa * Nature China * Nature India * Nature Italy * Nature Japan * Nature Korea * Nature Middle East * Privacy Policy * Use of cookies * Manage cookies/Do not sell my data * Legal notice * Accessibility statement * Terms & Conditions * California Privacy Statement Springer Nature (c) 2023 Springer Nature Limited